the 21st Century: The Endgame for Tobacco T-tests and multivariate linear regression models were conducted to compare cotinine levels between comparison groups. Result: Males and females were equally represented, with a mean age of 45.8 yrs (SD=12.6 years). Cigarette smokers had significantly higher cotinine levels (1477.4±1602 ng/ml) than non-smokers (57.6±155.2 ng/ml, p=0.02), and passive smokers (spouses of smokers) levels were intermediate (940.6±1719 ng/ml). Tobacco chewers had the highest cotinine levels of all groups (2779.9±2591 ng/ml) and the significant difference persisted after adjustment for age, sex, body mass index, and physical activity (p Conclusion: This is one of the first studies evaluating cotinine levels for smokeless tobacco in 24-hour urine samples in India. These findings require replication and suggest that combating nicotine dependency in chewers may be more difficult than in other tobacco users. Background: Smoking is the dominant form of tobacco globally. However in Asian countries like China, India and Indonesia which share the maximum burden of tobacco use, the use of smokeless form of tobacco is common. The adverse health and economic effect of smokeless tobacco is as harmful as that of smoking. In India, 75% of the tobacco users were smokeless tobacco users (SLT). Limited information is available at the population level on smokeless tobacco as a smoking cessation aid in India.
OP033 A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE HEALTH EFFECTS OF NON-SNUS SMOKELESS TOBACCO PRODUCTS
Background: Previous reviews on the health effects of smokeless tobacco have included Swedish snus, which is known to be less harmful than conventional products, and preparations containing betel nut which is independently carcinogenic. Objective: This systematic review seeks to determine risk of oral squamous cell carcinoma (OSCC), leukoplakia, periodontal disease, pancreatic cancer and adverse foetal outcomes in users of non-snus smokeless tobacco products (NSST). Method: Systematic review and meta-analysis was conducted in accordance with Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Pooled odds ratios and 95% confidence intervals were estimated by using random-effect models. We searched Medline, Embase and PsycInfo; no language restrictions were imposed. The primary outcomes were OSCC, leukoplakia, periodontal disease, pancreatic cancer and adverse foetal outcomes. All forms of smokeless tobacco from different countries, except snus and the ones containing betel nut, were considered as exposures. Result: A total of 25 studies from 7 different countries were included, of which 19 could be included in the meta-analysis. NSST was significantly associated with an increased risk of leukoplakia (OR=13.46; 95% CI: 4.29 to 42.25; I2=98%) and nearly doubled the risk of OSCC (OR=1.84; 95% CI: 0.83 to 4.07; I2=95%). However, NSST use had no significant effect on the risk of pancreatic cancer (OR=1.04; 95% CI: 0.47 to 2.32; I2=59%). Adverse fetal outcomes were only considered in one study which found that NSST use during pregnancy decreased mean birth weight of the infant by 17.1g (95% CI: 103 to 69). It was not possible to calculate pooled estimates for studies considering periodontal disease due to insufficient data.
Conclusion:
NSST users are at significantly increased risk of OSCC and leukoplakia however no association was detected with pancreatic cancer. Few studies have been performed on other systemic diseases, in particular relating to pregnancy outcomes. The findings of this meta-analysis reaffirm the vastly heterogeneous nature of smokeless tobacco products around the world. Despite the exclusion of potential confounding factors (South Asian products containing betel nut) and products with markedly different manufacturing processes (snus from Sweden), extreme levels of heterogeneity were observed which makes it critical for future global research on smokeless tobacco to identify a firm means of classifying and assimilating evidence on smokeless tobacco. (Bangladesh, China, India, Indonesia, Malaysia, Philippines, Thailand, and Vietnam) to determine the prevalence of a variety of other tobacco product use (defined and non-manufactured cigarettes). Recent trends in market growth of other tobacco products, along with price and taxation data, were also analysed where this information was available. Results: While the types of other tobacco product use varies between countries, prevalence of use of these products represents a significant proportion of overall tobacco use in several of the countries studied. Analyses of available tax data has shown that several of the products looked at were taxed at significantly lower rates than manufactured cigarettes. Conclusions: Other tobacco product use represents a significant portion of the tobacco-related health burden in several countries in South-East Asia. The findings of this study point to a need for improved surveillance to better identify trends in the use of other tobacco products, and for policies to reduce demand for these products.
OP039

The political landscape for the tobacco endgame OP001 REGULATING INDUSTRY INTERFERENCE & WHO FCTC IMPLEMENTATION: ARTICLE 5.3 & THE FUTURE OF GLOBAL HEALTH
Jeff Collin, Sarah Johnston, Evgeniya Plotnikova, Sarah Hill.
University of Edinburgh, United Kingdom
Background: Unlike other producers of unhealthy commodities, tobacco companies are now widely viewed as vectors of disease, with whom partnership approaches are recognised as unacceptable in policy and in science and from whom voluntary initiatives are seen as inadequate. The fundamental conflict of interest between the tobacco industry and health receives unique recognition in Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC), under which states must protect the development of public health policies from tobacco industry interference. Yet the extent to which parties are committed to implementing Article 5.3 can appear questionable. Method: We examined FCTC implementation reports from 161 countries to assess country perceptions of the extent of implementation of Article 5.3 and of tobacco industry interference as a barrier to FCTC implementation. Result: Overall, 54% of FCTC parties report having adopted and implemented programmes to protect tobacco control policies from the vested interests of the tobacco industry. This figure masks substantial variation when countries are organized by World Bank income categories; only one third of low income countries and under half of high income countries report implementing such programmes. Variation is more pronounced across WHO regions; whereas almost three quarters of countries from the Eastern Mediterranean Region claim to have implemented such measures, almost two thirds of the African Region report no such progress. Fewer countries claim to have implemented measures to ensure public access to information on industry activities; three quarters of both low-and high-income countries report no such measures. Comments provided within the implementation reports suggest low compliance with specific recommendations made in the implementation guidelines for Art. 5.3. Only 9 countries identified Art. 5.3 as a priority for further FCTC implementation, while one fifth of parties identified tobacco industry interference and tactics as barriers to implementation more broadly.
Conclusion:
The successful implementation of Art. 5.3 is widely recognised as critical to the overall success of the FCTC, and the limited evidence of active measures reported in these reports raise serious concerns. While issues of resources and capacity might explain limited progress in much of the Global South, the disappointing levels of implementation in high income countries rather suggest limited political commitment. This is echoed by the limited interpretation of Art. 5.3 that characterises some national tobacco control plans. While Art. 5.3 is increasingly seen as a model that might be applicable to other industries, this analysis shows that substantial work needs to be done within tobacco control to consolidate this approach. Increasing policy interest in harm reduction and innovative products may further hinder such progress. Background: Law as an instrument of social transformation helps in creating public awareness strengthens public policies and redresses injuries. The legislature realized the hazardous effects of tobacco use which has resulted in drafting of the pertinent tobacco control laws. The Judiciary has complemented these legitimate goals of public health pronouncing tobacco control initiatives as imperative to realization of fundamental right to life. The Supreme Court of India in 2001 itself banned smoking in public places throughout the country and since has upheld several tobacco control provisions under its domestic laws. Recently health rights judgments from Australia, Latin America, Colombia, South Africa, Argentina, Brazil & Canada strengthened tobacco control enforceability and these judicial precedents have provided strength to the much awaited goal of the endgame for tobacco. Objective: This paper will present a review of the judicial pronouncements in enforcing right to health as a concomitant part of the Indian constitution with special reference to tobacco control litigations in India Method: Review of primary sources such as Indian Tobacco Control Laws, the Constitution of India and key tobacco control litigations from India and other countries have been undertaken. Result: The Courts in India have played a significant role in realization of the right to health by recognizing it as a part of the fundamental right to life and issued suitable directions to the state authorities for the fulfilment of their duties. Similarly, for the effectiveness of tobacco control in India, judiciary has come up with path breaking judgments from enforcing the ban on smoking in public places to imposing a ban on sale of gutkha (smokeless) products across the country and have paved the way for achieving the goal of a tobacco free society. Conclusion: This paper identifies series of judgments passed in public interest and role of judiciary in progressive realization of the right to health. The judiciary has played a vital role in enforcing tobacco control laws in India by creating a promising scenario for successful implementation of stronger and effective tobacco control measures.
OP017 FCTC ARTICLE 5.3 & GOOD GOVERNANCE/ANTI-CORRUPTION MEASURES: HOW TO ACCELERATE ARTICLE 5.3 IMPLEMENTATION
John Stewart, Cloe Franko. Corporate Accountability International, United States
Background: Big Tobacco' s future hinges on its ability to interfere in public health laws. The world' s first public health and corporate accountability treaty, the Framework Convention on Tobacco Control (FCTC), includes a critical provision, Article 5.3, which states the tobacco industry has an irreconcilable conflict of interest with public health. Article 5.3 is already paying dividends for public health. However, its incorporation into national legislation has been slower than other FCTC articles, in part because Article 5.3 is a good governance measure that limits corporate interference in policymaking. The tobacco control movement has spent decades devising a good governance framework for tobacco products to regulate the industry and protect public health policies from commercial interests. The tobacco industry has a long history of corrupt conduct. Corruption in the context of tobacco control ranges the gamut of tobacco industry interference tactics fueling fraudulent conduct by those in power. Objective: 1. Encourage policymakers and advocates to accelerate implementation of Article 5.3 into national legislation. 2. Make the case that Article 5.3 and its guidelines can be considered anticorruption measures and that this comparison can be a powerful tool for advocacy and to accelerate enforcement. 3. Share successful case studies and ideas for how to mobilize the anticorruption and transparency community. Method: Survey of policymakers, tobacco control, transparency and anticorruption organizations, research of case studies of tobacco industry interference that have used anti-corruption laws to challenge the industry and policymakers that have violated Article 5.3 and research of existing anticorruption law and how it compares to Article 5.3 and its guidelines. Result: Because the tobacco industry has a history of fomenting corrupt practices among policymakers, insulating public policymaking from tobacco industry interference and increasing transparency is, in actually, an anti-corruption measure. This is precisely what Article 5.3 aims to do. Article 5.3 and its guidelines can be incorporated into existing anti-corruption measures like codes of conduct or enforcement mechanisms. Conclusion: National anti-corruption laws present an opportunity to strengthen the implementation and enforcement of Article 5.3 provisions. Anti-corruption laws apply broadly to government officials across agencies to further public health policy. 
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OP038 ENDGAME FOR MENTHOL AND SLIM CIGARETTES IN EUROPE? POLAND -THE LAST HURDLE
Mateusz Zygmunt Zatonski. Health Promotion Foundation, Poland
Background: In internal tobacco industry documents, menthol and "slim" cigarettes appear as key products for enticing teenagers into smoking, and in Japan, Finland, or Poland account for over 1/5 of the tobacco market share. In December 2012 the EU Commission proposed to update the Tobacco Products Directive, including a ban on the sale of flavoured and "slim" cigarettes (FaSCs) in the EU. While the majority of EU countries support this proposal, the Polish Ministry of Agriculture, urged by Polish tobacco growers and many MPs, has called the government to block the update. Objective: 1) Identify the key stakeholders among the Polish and EU bodies involved in the discussion over the sale of FaSCs since December 2012. 2) Classify their position, and assess their relative impact on the eventual outcome of the debate. Method: Qualitative analysis and synthesis of primary and secondary sources released by the EU during the update' s formulation, and of sources documenting the attitudes towards this proposal, e.g. EU Commission update proposal and impact assessment, Eurobarometer survey on Europeans attitudes towards tobacco (May 2012), Euromonitor tobacco in Poland report (September 2012) , and documents analysing the impact of the update on Poland released by tobacco companies, the pro-tobacco lobby, the anti-tobacco lobby, Polish governmental agencies, and the reception of the update in the Polish parliament and media. Result: Eight principal stakeholders were identified that could be grouped as: public opinion (Polish citizens, media), lobbyists (pro-tobacco and pro-health groups), political bodies (EU Commission, Polish Health Ministry, Polish Agri-
